Calidi Biotherapeutics Secures $4.6M in Warrant Exercise to Advance Cancer Therapies
July 10, 2025 — Calidi Biotherapeutics announces $4.6M warrant exercise to fund cancer therapy advancements, leveraging stem cell-based platforms for innovative treatment solutions.